Page 233 - Read Online

Singh et al. Myocardial protection in cardiac transplantation

16. Blaisdell FW, Cooley DA. The mechanism of paraplegia after 35. James H. Southard MDa, Folkert O. Belzer MD. ORGAN
temporary thoracic aortic occlusion and its relationship to spinal fluid PRESERVATION. Ann Rev Med 1995;46:235-47.
pressure. Surgery 1962;51:351-5. 36. Ploeg RJ, Goossens D, McAnulty JF, Southard JH, Belzer FO.
17. Kay EB, Head LR, Nogueira C. Direct coronary artery perfusion Successful 72-hour cold storage of dog kidneys with UW solution.
for aortic valve surgery; report of technique. J Am Med Assoc Transplantation 1988;46:191-6.
1958;168:1767-8. 37. Todo S, Nery J, Yanaga K, Podesta L, Gordon RD, Starzl TE.
18. Senning A. Ventricular fibrillation during hypothermia, used as Extended preservation of human liver grafts with UW solution. JAMA
a method to facilitate intracardiac operations. Acta Chir Scand 1989;261:711-4.
1955;109:303-9. 38. Jamieson NV, Sundberg R, Lindell S, Claesson K, Moen J,
19. Bretschneider HJ, Hübner G, Knoll D, Lohr B, Nordbeck H, Vreugdenhil PK, Wight DG, Southard JH, Belzer FO. Preservation of
Spieckermann PG. Myocardial resistance and tolerance to ischemia: the canine liver for 24-48 hours using simple cold storage with UW
physiological and biochemical basis. J Cardiovasc Surg (Torino) solution. Transplantation 1988;46:517-22.
1975;16:241-60. 39. Kozlova I, Khalid Y, Roomans GM. Preservation of mouse liver
20. Hearse DJ, Stewart DA, Braimbridge MV. Cellular protection during tissue during cold storage in experimental solutions assessed by x-ray
myocardial ischemia: the development and characterization of a microanalysis. Liver Transpl 2003;9:268-78.
procedure for the induction of reversible ischaemic arrest. Circulation 40. Vreugdenhil PK, Belzer FO, Southard JH. Effect of cold storage on
1976;54:193-202. tissue and cellular glutathione. Cryobiology 1991;28:143-9.
21. Buckberg GD. Recent progress in myocardial protection during 41. Biguzas M, Jablonski P, Howden BO, Thomas AC, Walls K, Scott DF,
cardiac operations. Cardiovasc Clin 1987;17:291-319. Marshall VC. Evaluation of UW solution in rat kidney preservation.
22. Hearse DJ, Humphrey SM, Nayler WG, Slade A, Border D. II. The effect of pharmacological additives. Transplantation
Ultrastructural damage associated with reoxygenation of the anoxic 1990;49:1051-5.
myocardium. J Mol Cell Cardiol 1975;7:315-24. 42. Kur F, Beiras-Fernandez A, Meiser B, Uberfuhr P, Reichart B.
23. Chambers DJ, Fallouh HB. Cardioplegia and cardiac surgery: Clinical heart transplantation with extended preservation time (>5
pharmacological arrest and cardioprotection during global ischemia hours): experience with University of Wisconsin solution. Transplant
and reperfusion. Pharmacol Ther 2010;127:41-52. Proc 2009;41:2247-9.
24. Reichenspurner H, Russ C, Uberfuhr P, Nollert G, Schlüter A, 43. Jeevanandam V, Barr ML, Auteri JS, Sanchez JA, Fong J, Schenkel
Reichart B, Klövekorn WP, Schüler S, Hetzer R, Brett W. Myocardial FA, Marboe CC, Michler RE, Smith CR, Rose EA.University of
preservation using HTK solution for heart transplantation. A Wisconsin solution versus crystalloid cardioplegia for human donor
multicenter study. Eur J Cardiothorac Surg 1993;7:414-9. heart preservation. A randomized blinded prospective clinical trial. J
25. Sung SY, Lin CY, Song JY, Tsai YT, Kao CH, Lee CY, Lin YC, Thorac Cardiovasc Surg 1992;103:194-8; discussion 198-9.
Hsu PS, Tsai CS. Myocardial protection in donor heart preservation: 44. Mankad P, Slavik Z, Yacoub M. Endothelial dysfunction caused by
a comparison between Bretschneider’s histidine-tryptophan- University of Wisconsin preservation solution in the rat heart. The
ketoglutarate solution and cold blood cardioplegia. Transplant Proc importance of temperature. J Thorac Cardiovasc Surg 1992;104:1618-24.
2014;46:1077-81. 45. Saitoh Y, Hashimoto M, Ku K, Kin S, Nosaka S, Masumura S, Nakayama
26. Minami K, Omoto T, Böthig D, Tenderich G, Wlost S, Schütt U, K. Heart preservation in HTK solution: role of coronary vasculature in
Körfer R. Creatine kinase and troponin after myocardial preservation recovery of cardiac function. Ann Thorac Surg 2000;69:107-12.
using HTK solution (Custoidol) for clinical heart transplantation. J 46. De Santo LS, Amarelli C, Romano G, Della Corte A, Maiello C,
Heart Lung Transplant 2003;22:192-4. Giannolo B, Marra C, De Feo M, Scardone M, Cotrufo M. High-
27. Larsen M, Webb G, Kennington S, Kelleher N, Sheppard J, Kuo J, risk heart grafts: effective preservation with Celsior solution. Heart
Unsworth-White J. Mannitol in cardioplegia as an oxygen free radical Vessels 2006;21:89-94.
scavenger measured by malondialdehyde. Perfusion 2002;17:51-5. 47. Careaga G, Salazar D, Téllez S, Sánchez O, Borrayo G, Argüero
28. Cordell AR. Milestones in the development of cardioplegia. Ann R. Clinical impact of histidine-ketoglutarate-tryptophan (HTK)
Thorac Surg 1995;60:793-6. cardioplegic solution on the perioperative period in open heart surgery
29. Chambers DJ, Sakai A, Braimbridge MV, Kosker S, Manzanera patients. Arch Med Res 2001;32:296-9.
G, Kind PR, Jupp RA, Smith LD, Slavin B.Clinical validation of 48. Lee KC, Chang CY, Chuang YC, Sue SH, Yang HS, Weng CF, Lee
St. Thomas’ hospital cardioplegic solution No. 2 (Plegisol). Eur J YT, Huang WS, Chen IC, Wei J.Combined St. Thomas and histidine-
Cardiothorac Surg 1989;3:346-52. tryptophan-ketoglutarat solutions for myocardial preservation in heart
30. Luciani GB, Faggian G, Montalbano G, Casali G, Forni A, Chiominto transplantation patients. Transplant Proc 2012;44:886-9.
B, Mazzucco A. Blood versus crystalloid cardioplegia for myocardial 49. Careaga G, Salazar D, Téllez S, Sánchez O, Borrayo G, Argüero
protection of donor hearts during transplantation: a prospective, R.Clinical impact of histidine-ketoglutarate-tryptophan (HTK)
randomized clinical trial. J Thorac Cardiovasc Surg 1999;118:787-95. cardioplegic solution on the perioperative period in open heart surgery
31. Luciani GB, Forni A, Rigatelli G, Chiominto B, Cardaioli P, Mazzucco patients. Arch Med Res 2001;32:296-9.
A, Faggian G. Myocardial protection in heart transplantation using 50. Vega JD, Ochsner JL, Jeevanandam V, McGiffin DC, McCurry KR,
blood cardioplegia: 12-year outcome of a prospective randomized Mentzer RM Jr, Stringham JC, Pierson RN 3rd, Frazier OH, Menkis
trial. J Heart Lung Transplant 2011;30:29-36. AH, Staples ED, Modry DL, Emery RW, Piccione W Jr, Carrier M,
32. Collins GM, Hartley LC, Clunie GJ. Kidney preservation for Hendry PJ, Aziz S, Furukawa S, Pham SM. A multicenter, randomized,
transportation. Experimental analysis of optimal perfusate controlled trial of Celsior for flush and hypothermic storage of cardiac
composition. Br J Surg 1972;59:187-9. allografts. Ann Thorac Surg 2001;71:1442-7.
33. Andrews PM, Bates SB. Improving Euro-Collins flushing solution’s 51. Wieselthaler GM, Chevtchik O, Konetschny R, Moidl R, Mallinger R,
ability to protect kidneys from normothermic ischemia. Miner Mares P, Griessmacher A, Grimm M, Wolner E, Laufer G. Improved
Electrolyte Metab 1985;11:309-13. graft function using a new myocardial preservation solution: Celsior.
34. Hendry PJ, Labow RS, Keon WJ. A comparison of intracellular Preliminary data from a randomized prospective study. Transplant
solutions for donor heart preservation. J Thorac Cardiovasc Surg Proc 1999;31:2067-8.
1993;105:667-73. 52. Cannata A, Botta L, Colombo T, Russo CF, Taglieri C, Bruschi G,

226 Vessel Plus ¦ Volume 1 ¦ December 28, 2017